Table 2.
The pathologic results and follow-up results of solitary pulmonary lesions in each group
| Groups | Total | FUG | CUG | MFUG | MUG | NUG |
|---|---|---|---|---|---|---|
| Malignant | 89 | 63 | 16 | 2 | 5 | 3 |
| Adenocarcinoma | 59 | 40 | 11 | 2 | 5 | 1 |
| Squamous cell carcinoma | 16 | 12 | 4 | |||
| Adenosquamous carcinoma | 2 | 1 | 1 | |||
| Small cell lung cancer | 7 | 7 | ||||
| Neuroendocrine carcinoma | 4 | 3 | 1 | |||
| Primitive neuroectodermal tumor | 1 | 1 | ||||
| Benign | 50 | 12 | 7 | 10 | 7 | 14 |
| Inflammatory pseudotumor | 10 | 5 | 1 | 3 | 1 | |
| Tuberculosis | 7 | 2 | 1 | 2 | 1 | 1 |
| Lung abscess | 4 | 4 | ||||
| Cartilaginous hamartoma | 4 | 1 | 1 | 2 | ||
| Isolated fibrous tumor | 2 | 2 | ||||
| Sclerosing hemangioma | 1 | 1 | ||||
| Neurilemmoma | 1 | 1 | ||||
| Benign in the follow-up period | 21 | 4 | 1 | 4 | 3 | 9 |
FUG full up take group, CUG circular uptake group, MFUG multi-focus uptake group, MUG mild uptake group, NUG no-uptake group